1-ALPHA,25-DIHYDROXYVITAMIN-D3 INHIBITS PRODUCTIVE INFECTION OF HUMAN MONOCYTES BY HIV-1

Pretreatment of freshly isolated human peripheral blood monocytes with the steroid hormone, lα,25-dihydroxyvitamin D3 (1,25(OH)D), markedly reduced (by 95% ) productive infection of human monocytes by HIV-1. Equivalent concentrations (10nM) of 25-hydroxyvitamin D3 (25(OH)D), the biologic precursor of 1,25(OH)D, were ineffective at reducing either CD4 expression or HIV-1 production. Pretreatment was required for modulation of HIV-1 infection by 1,25(OH)D. Interestingly, 1,25(OH)D-mediated decreases in p24 antigen production were observed prior to any observed reduction in CD4 expression, suggesting that 1,25(OH)D treatment may modulate HIV-1 infection of monocytes through additional factors besides decreased HIV-1 binding. These data raise the possibility that 1,25(OH)D compounds may be important in host resistance to HIV-1. © 1991 Academic Press, Inc.